Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002;4 Suppl 5(Suppl 5):S3-S10.

Risk factors for prostate cancer

Peter H Gann

Risk factors for prostate cancer

Peter H Gann. Rev Urol. 2002.

Abstract

The incidence of prostate cancer in the United States has recently undergone dramatic and unprecedented changes. Exposure to prostate-specific antigen testing has led to a steep increase in reported incidence. The data indicate that the strongest risk factors for prostate cancer are age and African American race/ethnicity. Family history is also an important risk factor for prostate cancer, although only a small proportion of cases will be due to high-penetrance genes such as those at the putative susceptibility loci (eg, ELAC2) recently identified through linkage analysis. International variation in the risk of prostate cancer is profound, as is the frequency with which migrants from low- to high-risk areas adopt the risk pattern of the host country, possibly within a single generation. This article reviews the current state of knowledge regarding risk factors for prostate cancer, including factors related to diet, anthropometrics, hormone profiles, and concomitant medical conditions. The need for unifying, overarching hypotheses is emphasized, along with identification of some of the barriers to future progress in the field.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-adjusted incidence and mortality of prostate cancer in the United States, 1973–1999 (Surveillance, Epidemiology, and End Results Program data).
Figure 2
Figure 2
Prostate cancer risk by quartile of plasma testosterone and sex hormone-binding globulin (SHBG): simultaneous adjustment for testosterone, SHBG, and estradiol (Physicians’ Health Study).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Etzioni R, Legler JM, Feuer EJ, et al. Cancer surveillance series: interpreting trends in prostate cancer-part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst. 1999;91:1033–1039. - PubMed
    1. Yatani R, Chigusa I, Akazaki K, et al. Geographic pathology of latent prostatic carcinoma. Int J Cancer. 1982;29:611–616. - PubMed
    1. Carter BS, Beaty TH, Steinberg GD, et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA. 1992;89:3367–3371. - PMC - PubMed
    1. Tavtigian SV, Simard J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet. 1001;27:134–135. - PubMed
    1. Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev. 2001;23:19–23. - PubMed

LinkOut - more resources